Esophagoprotective potential of cisapride: an additional benefit for gastroesophageal reflux disease
Cisapride is a novel prokinetic agent that releases acetylcholine at the level of the myenteric plexus. Acetylcholine also plays a role in the secretory function of salivary glands evoked by intraesophagal mechanical and chemical stimulation, mediated through the esophagosalivary reflex. The impact,...
Saved in:
Published in | Digestive diseases and sciences Vol. 42; no. 7; pp. 1362 - 1369 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Heidelberg
Springer
01.07.1997
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cisapride is a novel prokinetic agent that releases acetylcholine at the level of the myenteric plexus. Acetylcholine also plays a role in the secretory function of salivary glands evoked by intraesophagal mechanical and chemical stimulation, mediated through the esophagosalivary reflex. The impact, however, of cisapride on salivary protective components mediated by esophagosalivary reflex remains unknown. Therefore, we have studied salivary pH, bicarbonate, nonbicarbonate, glycoconjugate, protein, EGF, TGF-alpha, and PGE2 before and after the administration of cisapride. The study was conducted in 20 asymptomatic volunteers (9 women and 11 men, mean age 36, range 26-52). Salivary secretions were collected under basal conditions and during masticatory, mechanical, and chemical stimulation before and after four days of cisapride administration (10 or 20 mg four times a day). Cisapride administration resulted in a 45% increase in salivary volume during the basal condition (P < 0.01), a 32% increase during mastication (P < 0.05), a 53% increase during mechanical (P < 0.05), and a 51% increase during chemical (P < 0.01) stimulation. Cisapride administration resulted also in a significant increase in salivary protein output (P < 0.05), salivary bicarbonate (P < 0.05), and nonbicarbonate buffers (P < 0.05), and salivary EGF (P < 0.05). Salivary glycoconjugate significantly increased only during mechanical stimulation with the catheter and at the end of the esophageal perfusion procedure (P < 0.05). Although a similar trend was also recorded during the analysis of salivary PGE2, this difference did not reach statistical significance. Salivary pH and TGF-alpha before and after cisapride administration remained unchanged. The stimulatory impact of cisapride on salivary volume and inorganic (bicarbonate and nonbicarbonate buffers) and organic (protein, glycoconjugate, and EGF) protective components would benefit patients with GERD and would also be potential therapy for xerostomia. |
---|---|
AbstractList | Cisapride is a novel prokinetic agent that releases acetylcholine at the level of the myenteric plexus. Acetylcholine also plays a role in the secretory function of salivary glands evoked by intraesophagal mechanical and chemical stimulation, mediated through the esophagosalivary reflex. The impact, however, of cisapride on salivary protective components mediated by esophagosalivary reflex remains unknown. Therefore, we have studied salivary pH, bicarbonate, nonbicarbonate, glycoconjugate, protein, EGF, TGF-alpha, and PGE2 before and after the administration of cisapride. The study was conducted in 20 asymptomatic volunteers (9 women and 11 men, mean age 36, range 26-52). Salivary secretions were collected under basal conditions and during masticatory, mechanical, and chemical stimulation before and after four days of cisapride administration (10 or 20 mg four times a day). Cisapride administration resulted in a 45% increase in salivary volume during the basal condition (P < 0.01), a 32% increase during mastication (P < 0.05), a 53% increase during mechanical (P < 0.05), and a 51% increase during chemical (P < 0.01) stimulation. Cisapride administration resulted also in a significant increase in salivary protein output (P < 0.05), salivary bicarbonate (P < 0.05), and nonbicarbonate buffers (P < 0.05), and salivary EGF (P < 0.05). Salivary glycoconjugate significantly increased only during mechanical stimulation with the catheter and at the end of the esophageal perfusion procedure (P < 0.05). Although a similar trend was also recorded during the analysis of salivary PGE2, this difference did not reach statistical significance. Salivary pH and TGF-alpha before and after cisapride administration remained unchanged. The stimulatory impact of cisapride on salivary volume and inorganic (bicarbonate and nonbicarbonate buffers) and organic (protein, glycoconjugate, and EGF) protective components would benefit patients with GERD and would also be potential therapy for xerostomia. Cisapride is a novel prokinetic agent that releases acetylcholine at the level of the myenteric plexus. Acetylcholine also plays a role in the secretory function of salivary glands evoked by intraesophagal mechanical and chemical stimulation, mediated through the esophagosalivary reflex. The impact, however, of cisapride on salivary protective components mediated by esophagosalivary reflex remains unknown. Therefore, we have studied salivary pH, bicarbonate, nonbicarbonate, glycoconjugate, protein, EGF, TGF-alpha, and PGE2 before and after the administration of cisapride. The study was conducted in 20 asymptomatic volunteers (9 women and 11 men, mean age 36, range 26-52). Salivary secretions were collected under basal conditions and during masticatory, mechanical, and chemical stimulation before and after four days of cisapride administration (10 or 20 mg four times a day). Cisapride administration resulted in a 45% increase in salivary volume during the basal condition (P < 0.01), a 32% increase during mastication (P < 0.05), a 53% increase during mechanical (P < 0.05), and a 51% increase during chemical (P < 0.01) stimulation. Cisapride administration resulted also in a significant increase in salivary protein output (P < 0.05), salivary bicarbonate (P < 0.05), and nonbicarbonate buffers (P < 0.05), and salivary EGF (P < 0.05). Salivary glycoconjugate significantly increased only during mechanical stimulation with the catheter and at the end of the esophageal perfusion procedure (P < 0.05). Although a similar trend was also recorded during the analysis of salivary PGE2, this difference did not reach statistical significance. Salivary pH and TGF-alpha before and after cisapride administration remained unchanged. The stimulatory impact of cisapride on salivary volume and inorganic (bicarbonate and nonbicarbonate buffers) and organic (protein, glycoconjugate, and EGF) protective components would benefit patients with GERD and would also be potential therapy for xerostomia. |
Author | MCCALLUM, R. W SAROSIEK, J ZBROCH, T GOLDIN, G. F MARCINKIEWICZ, M BITYUTSKIY, L. P |
Author_xml | – sequence: 1 givenname: G. F surname: GOLDIN fullname: GOLDIN, G. F organization: University of Kansas Medical Center, Kansas City, Kansas 66160, United States – sequence: 2 givenname: M surname: MARCINKIEWICZ fullname: MARCINKIEWICZ, M organization: University of Kansas Medical Center, Kansas City, Kansas 66160, United States – sequence: 3 givenname: T surname: ZBROCH fullname: ZBROCH, T organization: University of Kansas Medical Center, Kansas City, Kansas 66160, United States – sequence: 4 givenname: L. P surname: BITYUTSKIY fullname: BITYUTSKIY, L. P organization: University of Kansas Medical Center, Kansas City, Kansas 66160, United States – sequence: 5 givenname: R. W surname: MCCALLUM fullname: MCCALLUM, R. W organization: University of Kansas Medical Center, Kansas City, Kansas 66160, United States – sequence: 6 givenname: J surname: SAROSIEK fullname: SAROSIEK, J organization: University of Kansas Medical Center, Kansas City, Kansas 66160, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2768802$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9246029$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkc1LxDAQxYMoun6cPQlFxNtqJmmaxpss6wcIXvRcpslEI91mbVrR_97ALh48zQzvxwzvzSHb7WNPjJ0CvwIu5DXeAIe6FqqCmpdyh81AaTnPc73LZhyq3ANUB-wwpQ_OudFQ7bN9I8qKCzNjbpni-h3f4nqII9kxfFGxzl0_BuyK6AsbEq6H4OimwL5A58IYYp-1lnryYSx8HIo3TOMQabOKsjiQ76bvwoVEmOiY7XnsEp1s6xF7vVu-LB7mT8_3j4vbp7mVuhznGgiF55oUetMK5QgtcqGsBIJSWi9l7ZQ1pUIko50vS219abxtUXHTyiN2udmbzXxOlMZmFZKlrsOe4pQabUALVUMGz_-BH3EasqvUiHxJGgCTobMtNLUrck1OYYXDT7PNLusXWx2Txc4P2Oew_jChq7rOL_oFBBaBLQ |
CODEN | DDSCDJ |
CitedBy_id | crossref_primary_10_1016_j_earlhumdev_2005_10_011 crossref_primary_10_1111_j_1572_0241_1999_1124_b_x crossref_primary_10_5056_jnm_2012_18_2_181 crossref_primary_10_1185_03007999809113354 crossref_primary_10_1016_j_advms_2014_08_005 crossref_primary_10_1053_bega_2000_0119 crossref_primary_10_1111_nyas_14521 crossref_primary_10_1046_j_1440_1746_1999_01939_x crossref_primary_10_1016_j_cgh_2007_01_002 crossref_primary_10_1080_00365520500463449 crossref_primary_10_1111_j_1440_1746_2010_06280_x crossref_primary_10_1046_j_1365_2036_2001_00902_x crossref_primary_10_1046_j_1365_2036_2002_01159_x crossref_primary_10_2165_00003495_200464040_00001 crossref_primary_10_1007_s12171_007_0007_z crossref_primary_10_1007_s11926_003_0008_6 crossref_primary_10_1046_j_1365_2036_2001_01080_x crossref_primary_10_1111_j_1442_2050_2004_00424_x crossref_primary_10_1097_MAJ_0000000000000443 crossref_primary_10_1111_nyas_12534 crossref_primary_10_1007_s10620_012_2430_y crossref_primary_10_1007_s11894_000_0063_3 crossref_primary_10_1111_j_1572_0241_2000_02198_x crossref_primary_10_1002_j_1536_4801_2002_tb07759_x crossref_primary_10_1016_S0163_7258_98_00021_7 crossref_primary_10_1097_00005176_200208000_00005 crossref_primary_10_1177_014107680309601002 crossref_primary_10_1046_j_1365_2036_2002_01225_x crossref_primary_10_1046_j_1365_2036_2000_00672_x crossref_primary_10_1111_j_1572_0241_2000_02003_x crossref_primary_10_1111_j_1572_0241_1999_1421_a_x |
ContentType | Journal Article |
Copyright | 1997 INIST-CNRS Copyright Kluwer Academic Publishers Jul 1997 |
Copyright_xml | – notice: 1997 INIST-CNRS – notice: Copyright Kluwer Academic Publishers Jul 1997 |
DBID | IQODW CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU FYUFA GHDGH K9- K9. KB0 M0R M0S M1P NAPCQ PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1023/a:1018825618043 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Nursing & Allied Health Database ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Consumer Health Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Essentials ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central Nursing & Allied Health Premium ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Essentials MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1573-2568 |
EndPage | 1369 |
ExternalDocumentID | 404215061 9246029 2768802 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C -~X .55 .86 .GJ .VR 06C 06D 08R 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 354 3V. 4.4 406 408 409 40D 40E 476 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8UJ 95- 95. 95~ 96X AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKAS AAKSU AANXM AANZL AAPBV AAQQT AARHV AARTL AATNV AATVU AAUGY AAUYE AAWCG AAWTL AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABPTK ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFO ACGFS ACHSB ACHVE ACHXU ACIGE ACIHN ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACREN ACTTH ACUDM ACVWB ACWMK ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADYOE ADZCM ADZKW AEAQA AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFFNX AFJLC AFKRA AFLOW AFNRJ AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHVUH AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BKNYI BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMJXF HQYDN HRMNR HZ~ I09 IAO IH2 IHE IJ- IKXTQ IMOTQ IQODW ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z J5H JBSCW JCJTX JZLTJ K9- KDC KOV KOW KPH L7B LAK LLZTM M0R M1P M4Y MA- MJL N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OHH OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RXW RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJN SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TAE TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW VVN W23 W48 WH7 WJK WK8 WOW X7M XOL YLTOR YOC Z45 Z7U Z7V Z7W Z7X Z81 Z82 Z83 Z87 Z88 Z8O Z8P Z8Q Z8R Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZXP ZY1 ~EX ~KM AACDK AAEOY AAJBT AASML AAYZH ABAKF ABJNI ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU AJOOF ALIPV CGR CUY CVF ECM EIF HMCUK HVGLF IHR NPM 7XB 8FK K9. PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c374t-71ea2f07e5af9b25deaca025c31e143cf338d5c945aae97df447cf49fcba509b3 |
IEDL.DBID | BENPR |
ISSN | 0163-2116 |
IngestDate | Sat Aug 17 02:58:07 EDT 2024 Thu Oct 10 19:25:49 EDT 2024 Wed Oct 16 00:51:19 EDT 2024 Sun Oct 29 17:08:23 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Human Gastroesophageal reflux Cisapride Secretion Treatment efficiency Esophageal disease Salivary gland Pharmacology Cytoprotector Digestive diseases Acetylcholine Biological effect Mechanism of action Endocrinology Antiemetic |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c374t-71ea2f07e5af9b25deaca025c31e143cf338d5c945aae97df447cf49fcba509b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 9246029 |
PQID | 214339119 |
PQPubID | 41056 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_79172581 proquest_journals_214339119 pubmed_primary_9246029 pascalfrancis_primary_2768802 |
PublicationCentury | 1900 |
PublicationDate | 1997-07-01 |
PublicationDateYYYYMMDD | 1997-07-01 |
PublicationDate_xml | – month: 07 year: 1997 text: 1997-07-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Heidelberg |
PublicationPlace_xml | – name: Heidelberg – name: United States – name: New York |
PublicationTitle | Digestive diseases and sciences |
PublicationTitleAlternate | Dig Dis Sci |
PublicationYear | 1997 |
Publisher | Springer Springer Nature B.V |
Publisher_xml | – name: Springer – name: Springer Nature B.V |
SSID | ssj0009716 |
Score | 1.7176155 |
Snippet | Cisapride is a novel prokinetic agent that releases acetylcholine at the level of the myenteric plexus. Acetylcholine also plays a role in the secretory... |
SourceID | proquest pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 1362 |
SubjectTerms | Adult Biological and medical sciences Catheterization Cisapride Digestive system Esophagus - drug effects Female Gastroesophageal Reflux - drug therapy Gastrointestinal Agents - pharmacology Humans Hydrogen-Ion Concentration Male Medical sciences Perfusion Pharmacology. Drug treatments Piperidines - pharmacology Saliva - chemistry Saliva - drug effects Saliva - metabolism Salivary Proteins and Peptides - analysis Salivary Proteins and Peptides - drug effects Time Factors |
Title | Esophagoprotective potential of cisapride: an additional benefit for gastroesophageal reflux disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/9246029 https://www.proquest.com/docview/214339119 https://search.proquest.com/docview/79172581 |
Volume | 42 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED50AxFE_IlzOvPga3FN06bZi6hMRFBEFPZWkiYRQdq6duCf76WNUx_0rRC4lkvu7rvc9T6AUx6bJLWUB1wYHbAk0YGQOgx4aGNOFZVp3nb53ic3z-x2Fs98b07t2yq_fGLrqHWZuzvyM4qBPULLFOfVe-BIo1xx1TNorEIfl12Vtn85vX94_J66y1vuU4Q1UYCZTvJjto-cuFlVmB8lYTp2_-xsVLJGtdiOz-JvwNkGnust2PSIkVx0W7wNK6bYgbU7XxPfBT11TAQtnUk7cgHdF6nwqUDbfSOlJfgeWc1ftZmQi4K4BqLu_o8o9HP2tSGIW8mLrJt5aTpRCB4JRs63xQfxBZw9eL6ePl3dBJ47IcgjzhrUtZHUjrmJpRWKxhodrER8k0ehQU3mFlNTHeeCxVIawbVljOeWCZsriRhCRfvQK8rCHADRIkmNTBlGrohRw4UrxanIcKWYNkwN4PiX6rKqm5ORUUxl0jEdwPBLlZk3kDpbbucATpareLJduUIWplzUGcdMksZpOID9Tv9LwfgFyZiKw38FD2G9GzXrWmuPoNfMF-YYAUSjRrDKZ3zkD8snkc7IlA |
link.rule.ids | 315,786,790,12083,21416,27955,27956,31752,31753,33777,33778,43343,43838,74100,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB58gAoiPnF9bQ5ei9s0bRovsoiyPnZPu7C3kjSJLEhbt13w5ztpu6se9FYIpGUyj28y0_kArnloothS7nFhtMeiSHtCat_jvg05VVTGad3lO4oGE_Y8Dadtb07ZtlUufWLtqHWeujvyG4qBPUDLFHfFh-dIo1xxtWXQWIdNXGROzfmUf8_c5TXzKYKawMM8J_ox2UfeuklVmB1Fftxzf-zsFrJEodiGzeJvuFmHncd92GvxIuk3B3wAayY7hK1hWxE_Av3geAhqMpN64AI6L1LgU4aW-05yS_A9spjPtLkl_Yy49qHm9o8o9HJ2VhFEreRNltU8N81WCB0Jxs33xSdpyzfHMHl8GN8PvJY5wUsDziqUtJHU9rgJpRWKhhrdq0R0kwa-QTmmFhNTHaaChVIawbVljKeWCZsqiQhCBSewkeWZOQWiRRQbGTOMWwGjhgtXiFOB4UoxbZjqwOUv0SVFMyUjoZjIxD3agfOlKJPWPMpkdZgd6K5WUa9dsUJmJl-UCcc8koax34GTRv6rjfELoh4VZ_9u3IXtwXj4mrw-jV7OYacZOuuabC9go5ovzCVCiUpd1QrzBf3nyTQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB58gAgiPnF95uC12KZp03gRURffeFDYW0maRBakrdsu-POdtHHVg94KhbRMkplvMpPvAzjmiUkzS3nAhdEBS1MdCKmjgEc24VRRmRVdl-9jev3CbkfJyFMKNb6t8ssndo5aV4U7Iz-hGNhj3JnixPquiKfL4Vn9HjgBKVdo9Woa87CIQTJ0Kg58xL_5d3mngooAJw4w50l_sPzIU8dahZlSGmWhu72zUssGDWR7ZYu_oWcXgoZrsOqxIznvJ3sd5ky5AUsPvjq-CfrKaRJ0wiYd-QI6MlLjU4m7-I1UluB3ZD0Za3NKzkviWon6k0Ci0OPZcUsQwZJX2bSTyvRDIYwkGEPfph_El3K24GV49XxxHXgVhaCIOWvR6kZSG3KTSCsUTTS6WolIp4gjgzYtLCapOikES6Q0gmvLGC8sE7ZQEtGEirdhoaxKswNEizQzMmMYw2JGDReuKKdiw5Vi2jA1gINfpsvrnjEjp5jUZCEdwN6XKXO_VZp8NrEDOJq9xTXuCheyNNW0yTnmlDTJogFs9_afDYx_kIZU7P478BEs4VrJ728e7_Zgueefdf22-7DQTqbmAFFFqw679fIJFG3NYA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Esophagoprotective+potential+of+cisapride%3A+An+additional+benefit+for+gastroesophageal+reflux+disease&rft.jtitle=Digestive+diseases+and+sciences&rft.au=Goldin%2C+George+F&rft.au=Marcinkiewicz%2C+Marek&rft.au=Zbroch%2C+Tomasz&rft.au=Bityutskiy%2C+Leonid+P&rft.date=1997-07-01&rft.pub=Springer+Nature+B.V&rft.issn=0163-2116&rft.eissn=1573-2568&rft.volume=42&rft.issue=7&rft.spage=1362&rft_id=info:doi/10.1023%2Fa%3A1018825618043&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=404215061 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0163-2116&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0163-2116&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0163-2116&client=summon |